Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck.

Rodrigo JP, García LA, Ramos S, Lazo PS, Suárez C.

Clin Cancer Res. 2000 Aug;6(8):3177-82.

2.

Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.

Rodrigo JP, García-Carracedo D, García LA, Menéndez S, Allonca E, González MV, Fresno MF, Suárez C, García-Pedrero JM.

J Pathol. 2009 Mar;217(4):516-23. doi: 10.1002/path.2462.

PMID:
18991334
3.

Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis.

Meredith SD, Levine PA, Burns JA, Gaffey MJ, Boyd JC, Weiss LM, Erickson NL, Williams ME.

Arch Otolaryngol Head Neck Surg. 1995 Jul;121(7):790-4.

PMID:
7598859
4.

The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.

Akervall J, Bockmühl U, Petersen I, Yang K, Carey TE, Kurnit DM.

Clin Cancer Res. 2003 May;9(5):1750-5.

5.

EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.

Hui R, Campbell DH, Lee CS, McCaul K, Horsfall DJ, Musgrove EA, Daly RJ, Seshadri R, Sutherland RL.

Oncogene. 1997 Sep 25;15(13):1617-23.

6.

[Inactivation of p53 and amplification of cyclin D1 in squamous cell carcinomas of the head and neck].

Rodrigo Tapia JP, González Meana MV, García González LA, Coto E, García Pedrero J, Núñez Batalla F, Suárez Nieto C.

Acta Otorrinolaringol Esp. 2002 Apr;53(4):225-32. Spanish.

7.

Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.

Liu SC, Zhang SY, Babb JS, Ridge JA, Klein-Szanto AJ.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):455-9.

8.

[CCND1 oncogene amplification and cellular DNA content in squamous cell carcinomas of the head and neck].

Rodrigo Tapia JP, García González LA, Martínez Sánchez JA, González Meana MV, García Pedrero JM, Suárez Nieto C.

Acta Otorrinolaringol Esp. 2001 Oct;52(7):539-43. Spanish.

9.

Chromosome 11Q13 amplification in head and neck squamous cell carcinoma.

Williams ME, Gaffey MJ, Weiss LM, Wilczynski SP, Schuuring E, Levine PA.

Arch Otolaryngol Head Neck Surg. 1993 Nov;119(11):1238-43.

PMID:
8217084
10.

EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival.

Hui R, Ball JR, Macmillan RD, Kenny FS, Prall OW, Campbell DH, Cornish AL, McClelland RA, Daly RJ, Forbes JF, Blamey RW, Musgrove EA, Robertson JF, Nicholson RI, Sutherland RL.

Oncogene. 1998 Aug 27;17(8):1053-9.

11.

Amplifications of TAOS1 and EMS1 genes in oral carcinogenesis: association with clinicopathological features.

Xia J, Chen Q, Li B, Zeng X.

Oral Oncol. 2007 May;43(5):508-14. Epub 2006 Sep 26.

PMID:
17005439
12.

High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.

Zaharieva BM, Simon R, Diener PA, Ackermann D, Maurer R, Alund G, Knönagel H, Rist M, Wilber K, Hering F, Schönenberger A, Flury R, Jäger P, Fehr JL, Mihatsch MJ, Gasser T, Sauter G, Toncheva DI.

J Pathol. 2003 Dec;201(4):603-8.

PMID:
14648664
13.

Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.

Matthias C, Branigan K, Jahnke V, Leder K, Haas J, Heighway J, Jones PW, Strange RC, Fryer AA, Hoban PR.

Clin Cancer Res. 1998 Oct;4(10):2411-8. Erratum in: Clin Cancer Res 1999 Jan;5(1):222.

14.

A differential PCR system for the determination of CCND1 (cyclin D1) gene amplification in head and neck squamous cell carcinomas.

Schneeberger C, Eder S, Swoboda H, Ullrich R, Zeillinger R.

Oral Oncol. 1998 Jul;34(4):257-60.

PMID:
9813719
15.

[The relationship between human papillomavirus and cyclin D1 gene amplification in squamous cell carcinomas of the head and neck].

Rodrigo Tapia JP, García González LA, Alvarez Alvarez I, Cabanillas Farpón R, Suárez Nieto C.

Acta Otorrinolaringol Esp. 2005 Nov;56(9):428-33. Spanish.

16.

Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations.

Cuny M, Kramar A, Courjal F, Johannsdottir V, Iacopetta B, Fontaine H, Grenier J, Culine S, Theillet C.

Cancer Res. 2000 Feb 15;60(4):1077-83.

17.

Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications.

Bellacosa A, Almadori G, Cavallo S, Cadoni G, Galli J, Ferrandina G, Scambia G, Neri G.

Clin Cancer Res. 1996 Jan;2(1):175-80.

18.
19.
20.

MYC amplification in squamous cell carcinomas of the head and neck.

Rodrigo JP, Lazo PS, Ramos S, Alvarez I, Suárez C.

Arch Otolaryngol Head Neck Surg. 1996 May;122(5):504-7.

PMID:
8615967
Items per page

Supplemental Content

Write to the Help Desk